Evidence map›Paper›PMID 29374267›Full record

ArticleThe ISME journal2018

Quorum-sensing control of antibiotic resistance stabilizes cooperation in Chromobacterium violaceum.

Kara C Evans, Saida Benomar, Lennel A Camuy-Vélez, Ellen B Nasseri, Xiaofei Wang, Benjamin Neuenswander, Josephine R Chandler

Open access · bronzeAbstract read
In one paragraph

Article in The ISME journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Metabolomic Analysis of the Effect ofAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Efflux, Signaling and Warfare in a Polymicrobial World.Antibiotics (Basel, Switzerland) · 2023
    Review
  13. Combination of 2-mSphere · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kara C EvansDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Saida BenomarDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.ORCID http://orcid.org/0000-0003-2395-0343
Lennel A Camuy-VélezDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Ellen B NasseriDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Xiaofei WangDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Benjamin NeuenswanderChemical Methodologies and Library Development Legacy, University of Kansas, Lawrence, KS, 66045, USA.
Josephine R ChandlerDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA. jrchandler@ku.edu.
University of Kansas · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
Understanding the mechanobiology of stem cells in a microengineered 3D cardiac tissue environment with cardiomyopathyP20GM103638 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HOLMSTROM, ERIK D · 2012 to 2021
$22.1M
KU Post-Baccalaureate Research Education Program (PREP)R25GM078441 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI V GUSTAVO BLANCO, Paulyn Cartwright · 2006 to 2026
$6.6M
TRAINING GRANT IN DYNAMIC ASPECTS OF CHEMICAL BIOLOGYT32GM008545 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 1994 to 2019
$4.9M
Legacy continuation of the KU CMLD MissionR24GM111385 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI PRISINZANO, THOMAS EDWARD · 2014 to 2016
$1.5M
NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM103638NIGMS NIH HHS P20 GM113117NIGMS NIH HHS R24 GM111385NIGMS NIH HHS R25 GM078441NIGMS NIH HHS T32 GM008545
6 · The paper itself

Abstract

Many Proteobacteria use quorum sensing to regulate production of public goods, such as antimicrobials and proteases, that are shared among members of a community. Public goods are vulnerable to exploitation by cheaters, such as quorum sensing-defective mutants. Quorum sensing- regulated private goods, goods that benefit only producing cells, can prevent the emergence of cheaters under certain growth conditions. Previously, we developed a laboratory co-culture model to investigate the importance of quorum-regulated antimicrobials during interspecies competition. In our model, Burkholderia thailandensis and Chromobacterium violaceum each use quorum sensing-controlled antimicrobials to inhibit the other species' growth. Here, we show that C. violaceum uses quorum sensing to increase resistance to bactobolin, a B. thailandensis antibiotic, by increasing transcription of a putative antibiotic efflux pump. We demonstrate conditions where C. violaceum quorum-defective cheaters emerge and show that in these conditions, bactobolin restrains cheaters. We also demonstrate that bactobolin restrains quorum-defective mutants in our co-culture model, and the increase in antimicrobial-producing cooperators drives the C. violaceum population to become more competitive. Our results describe a mechanism of cheater restraint involving quorum control of efflux pumps and demonstrate that interspecies competition can reinforce cooperative behaviors by placing constraints on quorum sensing-defective mutants.

Indexed as

Drug Resistance, BacterialMicrobial InteractionsQuorum SensingBenzopyransBurkholderiaChromobacteriumbactobolinBenzopyrans

Identifiers

PMID29374267
PMCPMC5932061
OpenAlexW2791768957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.